1/12
10:37 am
neo
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
Low
Report
NeoGenomics (NASDAQ:NEO) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $14.00 price target on the stock.
1/12
10:31 am
neo
Rating for NEO
Low
Report
Rating for NEO
1/12
10:31 am
neo
Rating for NEO
Low
Report
Rating for NEO